XGN — Recent News Coverage
All news mentioning XGN in ESEN's AI-graded feed
News stories with XGN as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on XGN. See /coverage/XGN for the 30-day aggregate.
FLIPBOARD.COM
·
2026-08-11
LOW
BULLISH
CORR0.42
Exagen (XGN) Q2 2026 Earnings Call Transcript
$XGN
◈ ESEN AI
Exagen (XGN) reported record revenue in Q2 2026 alongside near break-even adjusted EBITDA, marking operational progress toward sustained profitability. The earnings call transcript itself constitutes a scheduled procedu…
SEEKINGALPHA.COM
·
2026-08-05
NEUTRAL
BULLISH
CORR0.42
Exagen: The Path To Profitability Just Became More Credible (NASDAQ:XGN)
$XGN
◈ ESEN AI
Exagen (XGN) is demonstrating operational inflection as its turnaround strategy yields tangible financial improvements. The emergence of operating leverage signals that management's cost discipline and revenue initiativ…
SEEKINGALPHA.COM
·
2026-08-04
NEUTRAL
BULLISH
CORR0.42
Exagen targets $72M-$75M 2026 revenue outlook as profitability nears breakeven (NASDAQ:XGN)
$XGN
◈ ESEN AI
Exagen (XGN) reported record Q2 2026 revenue of $19.9M and raised its full-year guidance to $72–$75M, signaling sustained operational momentum in the autoimmune diagnostic space. The guidance raise, coupled with margin …
SEEKINGALPHA.COM
·
2026-08-04
NEUTRAL
NEUTRAL
CORR0.15
Exagen Inc. (XGN) Q2 2026 Earnings Call Transcript
$XGN
◈ ESEN AI
Exagen Inc. (XGN) released Q2 2026 earnings results via earnings call on August 4, 2026. The company is a diagnostics and autoimmune disease testing provider, and quarterly earnings calls typically contain forward guida…
EXPLORE OTHER FILTERS